Ikonics Corporation (IKNX) Fundamental Analysis & Valuation

NASDAQ:IKNX

Current stock price

33.9
-0.1 (-0.29%)
Last:

This IKNX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. IKNX Profitability Analysis

1.1 Basic Checks

  • In the past year IKNX has reported negative net income.
IKNX Yearly Net Income VS EBIT VS OCF VS FCFIKNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 0 1M -1M

1.2 Ratios

Industry RankSector Rank
ROA -3.51%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IKNX Yearly ROA, ROE, ROICIKNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 0 -2 -4 -6 -8 -10

1.3 Margins

Industry RankSector Rank
OM -9.27%
PM (TTM) -2.66%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IKNX Yearly Profit, Operating, Gross MarginsIKNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 0 10 -10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. IKNX Health Analysis

2.1 Basic Checks

  • IKNX has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for IKNX is higher compared to a year ago.
IKNX Yearly Shares OutstandingIKNX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 500K 1M 1.5M 2M
IKNX Yearly Total Debt VS Total AssetsIKNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 5M 10M 15M

2.2 Solvency

  • IKNX has an Altman-Z score of 20.66. This indicates that IKNX is financially healthy and has little risk of bankruptcy at the moment.
  • There is no outstanding debt for IKNX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 20.66
ROIC/WACCN/A
WACCN/A
IKNX Yearly LT Debt VS Equity VS FCFIKNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 5M 10M

2.3 Liquidity

  • IKNX has a Current Ratio of 2.37. This indicates that IKNX is financially healthy and has no problem in meeting its short term obligations.
  • A Quick Ratio of 1.62 indicates that IKNX should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 1.62
IKNX Yearly Current Assets VS Current LiabilitesIKNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. IKNX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 78.07% over the past year.
  • Looking at the last year, IKNX shows a quite strong growth in Revenue. The Revenue has grown by 15.08% in the last year.
  • IKNX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.22% yearly.
EPS 1Y (TTM)78.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.28%
Revenue 1Y (TTM)15.08%
Revenue growth 3Y-7.99%
Revenue growth 5Y-5.22%
Sales Q2Q%51.55%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IKNX Yearly Revenue VS EstimatesIKNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 5M 10M 15M

More info and screens

Find the best growth stocksShow best growing peers

0

4. IKNX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IKNX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IKNX Price Earnings VS Forward Price EarningsIKNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -86.85
IKNX Per share dataIKNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IKNX Dividend Analysis

5.1 Amount

  • IKNX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

IKNX Fundamentals: All Metrics, Ratios and Statistics

Ikonics Corporation

NASDAQ:IKNX (12/13/2021, 8:39:49 PM)

33.9

-0.1 (-0.29%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners7.44%
Inst Owner Change-38.85%
Ins Owners38.56%
Ins Owner Change0%
Market Cap67.16M
Revenue(TTM)16.29M
Net Income(TTM)-434.02K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.12
P/FCF N/A
P/OCF N/A
P/B 6.6
P/tB N/A
EV/EBITDA -86.85
EPS(TTM)-0.16
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.22
BVpS5.14
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.51%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -9.27%
PM (TTM) -2.66%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.37
Quick Ratio 1.62
Altman-Z 20.66
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.28%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.08%
Revenue growth 3Y-7.99%
Revenue growth 5Y-5.22%
Sales Q2Q%51.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Ikonics Corporation / IKNX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of Ikonics Corporation (IKNX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to IKNX.


What is the valuation status for IKNX stock?

ChartMill assigns a valuation rating of 1 / 10 to Ikonics Corporation (IKNX). This can be considered as Overvalued.


Can you provide the profitability details for Ikonics Corporation?

Ikonics Corporation (IKNX) has a profitability rating of 2 / 10.


Can you provide the financial health for IKNX stock?

The financial health rating of Ikonics Corporation (IKNX) is 8 / 10.


Is the dividend of Ikonics Corporation sustainable?

The dividend rating of Ikonics Corporation (IKNX) is 0 / 10 and the dividend payout ratio is 0%.